Decreasing iron neurotoxicity in pantothenate kinase-associated neurodegeneration
Scott Ayton, Ashley I Bush
The Lancet Neurology | ELSEVIER SCIENCE INC | Published : 2019
SA and AIB report research grants from the Australian National Health and Medical Research Council and the US National Institutes of Health, relevant to this work. AIB is a shareholder in Alterity Ltd, Cogstate Ltd, Brighton Biotech LLC, Grunbiotics Pty Ltd, Eucalyptus Pty Ltd, and Mesoblast Ltd. He is a paid consultant for, and has a profit share interest in, Collaborative Medicinal Development Pty Ltd.